Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/08/056334
CTRI/2023/08/056334
Not yet recruiting
Phase 4

A Comparative Study on Efficacy and Safety of Low Dose Oral Minoxidil Versus Oral Finasteride in the Treatment of Male Androgenetic Alopecia - nil

Rithvik Mudalakatte Hegde0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Rithvik Mudalakatte Hegde
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Pms

Investigators

Sponsor
Rithvik Mudalakatte Hegde

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with clinical features of Androgenetic Alopecia in the age group of 18 years to 50 years presenting in the Department of Dermatology Venerology and Leprosy, of A.J Institute of Medical Science, Mangalore.
  • •2\. Patients with clinical features of Androgenetic Alopecia of grades II to V according to the Norwood\-Hamilton scale presenting in the Department of Dermatology Venerology and Leprosy, of A.J Institute of Medical Science, Mangalore.
  • •3\. Have Androgenetic Alopecia that in the opinion of the healthcare professional is suitable for treatment with both low dose oral minoxidil and oral finasteride.

Exclusion Criteria

  • •1\. Patients who are using and/or continuing other treatment modalities for androgenetic alopecia.
  • •2\. Patients who have abnormal blood pressure (BP), I.e. Systolic BP \< 90 or \> 180 mmHg and Diastolic BP \<60 or \> 120 mmHg.
  • •3\. Patients having abnormal liver function test.
  • •4\. Patients having a history of abnormal thyroid conditions.
  • •5\. Any unstable serious co\-existing medical conditions.
  • •6\. Patients with a history or current evidence of any serious and/or unstable pre\-existing medical or psychiatric disorder.
  • •7\. Patients diagnosed with pheochromocytoma.
  • •8\. Patients having any history of heart conditions or any abnormal cardiac examination findings.
  • •9\. Patients with a history of allergy to oral minoxidil/finasteride or its components.
  • •10\. Patients with a history of use of light or laser treatment of scalp.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
osartan - Metoprolol XL Combination in Essential Hypertension Along with Type II DiabetesHealth Condition 1: null- Essential Hypertension Along with Type II Diabetes
CTRI/2011/08/001937Ipca Laboratories Ltd158
Unknown
Not Applicable
Is spinal anaesthesia more safe and effective than general anaesthesia for open surgery of gall bladder?Health Condition 1: null- Uncomplicated symptomatic gallstone disease with ASA I or II physical status, aged between 18 and 70 years of either sex, and BMI â?¤ 30 kg/m2
CTRI/2015/04/005715Dr Ram Bhakta Koju120
Not yet recruiting
Not Applicable
A comparative study of effectiveness of Alpha2 agonist (Dexmedetomidine) versus opioid (fentanyl) for awake intubation using flexible bronchoscopeHealth Condition 1: O- Medical and Surgical
CTRI/2022/03/041196Vinayaka missions kirupanda variyar medical college and hospital
Not yet recruiting
Phase 2
A clinical trial to study the effects of two drugs, metformin lotion and zinc oxide cream in patients with melasma, a type of facial pigmentatioHealth Condition 1: L811- Chloasma
CTRI/2023/09/057901ITHYAMS
Completed
Phase 1
The effect of ajicoat and cadaver on burn treatment
IRCT20190807044468N1Esfahan University of Medical Sciences50